New tablet formulation of tacrolimus with smaller interindividual variability may become a better treatment option than the conventional capsule formulation in organ transplant patients

  • Yu Kyong Kim, Anhye Kim, Shin Jung Park, Howard Lee
  • Drug Design Development and Therapy, September 2017, Dove Medical Press
  • DOI: 10.2147/dddt.s142201

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.2147/dddt.s142201

The following have contributed to this page: Professor Howard Lee